Trial Profile
A Multicentre, Double-Blind, Randomized, Phase IV Clinical Trial Comparing the Safety, Tolerability and Efficacy of Levetiracetam Versus Lamotrigine and Carbamazepine in the Oral Antiepileptic Therapy of Newly Diagnosed Elderly Patients With Focal Epilepsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2018
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary) ; Carbamazepine; Lamotrigine
- Indications Partial epilepsies
- Focus Adverse reactions
- Acronyms STEP-ONE
- 03 Sep 2018 Results published in the Epilepsia.
- 02 Dec 2011 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
- 02 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.